IGMS's logo.
Ticker Symbol: IGMS

IGM Biosciences Inc

$60.54 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: United States Currency: USD Asset Type: Common Stock CIK:0001496323

Company Profile

Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 325 E Middlefield Rd
Website: igmbio.com
CEO: N/A
Tags:
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $6.71
Change: -$0.51 ( -7.06%)
Days Range: $6.64 - $7.37
Beta: 2.05
52wk. High: $28.20
52wk. Low: $4.09
Ytd. Change -64.62%
50 Day Moving Average: $6.46
200 Day Moving Average: $9.27
Shares Outstanding: 32865317

Valuation

Market Cap: 22.1B
PE Ratio: -1.27
EPS (TTM): -5.27

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A